Xcout Intel
Cartography Biosciences
Cartography Biosciences is a biotechnology company that uses single-cell genomics, proteomics, machine learning, and computational biology to analyze massive datasets of healthy and cancerous human cells. Through its platforms, the company identifies new therapeutic targets and develops precision molecules designed to target tumors while sparing healthy tissue.
Subscribe to see Cartography Biosciences’s full profile → the full roster, investors in every round, weekly hiring history and every corporate event
Cartography Biosciences at a glance
Cartography Biosciences is a biotechnology company headquartered in United States. Xcout tracks 17 named people at Cartography Biosciences, including Kevin Parker (Chief Executive Officer).
Cartography Biosciences leadership
- Kevin ParkerChief Executive Officer
- Dan RockChief Scientific Officer
- Dirk NagorsenChief Medical Officer
- Ansuman SatpathyBoard Director
- Jeffrey VerboonFounding Scientist & Executive Director Computational Biology
- Max MumbachFounding Scientist & Executive Director Target Discovery
11 more named people on record for Cartography Biosciences, with roles, board committees and tenure — see the full roster →
Cartography Biosciences competitors
A few of Cartography Biosciences's closest competitors — see the full list of competitors and alternatives →
Cellarity is a U.S. biotechnology company that uses single-cell biology, computational modeling, and machine learning to discover medicines based on cellular behaviors and disease mechanisms. It serves pharmaceutical and biotechnology development needs, advancing its own therapeutic programs and potentially partnering with other drug developers.
CellCarta operates as a global contract research organization (CRO) providing specialized laboratory testing and biomarker services to support drug development and precision medicine. The company offers a wide range of services including immunology, proteomics, genomics, histopathology, and companion diagnostic development for pharmaceutical and biotechnology clients.
Pathos AI, Inc. is an artificial-intelligence-driven biopharmaceutical company that uses multimodal patient and biological data to discover and develop precision medicines. Its work is focused primarily on oncology and serves patients with serious diseases through pharmaceutical and healthcare partnerships.
Character Biosciences is a biotechnology company that uses human genetics and functional genomics to discover and develop precision medicines. Its work has focused particularly on genetically informed therapies for age-related diseases, including ophthalmic conditions such as age-related macular degeneration.
Tyra Biosciences is a biotechnology company headquartered in Carlsbad, California, that develops next-generation precision medicines.
Atavistik Bio is a U.S. biotechnology company developing small-molecule medicines by targeting allosteric sites and metabolite-regulated biology, using its chemoproteomics and drug-discovery platform. Its programs are aimed at treating cancer and other serious diseases.
Get Cartography Biosciences's news by email
Funding rounds, acquisitions, new executives, launches and expansions, each with a two-line summary and a link to the source. One short email a day, only when there is news.
Free: up to 5 companies, daily. Subscribers also follow whole sectors and saved filters (M&A in Israel, AI funding…), get instant alerts, in-app notifications and signed webhooks, and open the full profile behind every name. Subscribe →
Something wrong or missing about Cartography Biosciences? Suggest a correction
Share this card
Post the link and the card appears automatically — each network fetches the image itself.
More on Cartography Biosciences in Xcout Intel
- 17 named people with titles, LinkedIn and board committees
- The full competitor set, tracking, exports and API access